nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS1—endothelium—acquired immunodeficiency syndrome	0.0079	0.0999	CbGeAlD
Trisalicylate-choline—PTGS2—endothelium—acquired immunodeficiency syndrome	0.00755	0.0955	CbGeAlD
Trisalicylate-choline—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.00702	0.0887	CbGeAlD
Trisalicylate-choline—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.00671	0.0848	CbGeAlD
Trisalicylate-choline—Magnesium salicylate—ALB—acquired immunodeficiency syndrome	0.00545	1	CrCbGaD
Trisalicylate-choline—PTGS1—skin of body—acquired immunodeficiency syndrome	0.00337	0.0426	CbGeAlD
Trisalicylate-choline—PTGS2—skin of body—acquired immunodeficiency syndrome	0.00322	0.0408	CbGeAlD
Trisalicylate-choline—PTGS1—digestive system—acquired immunodeficiency syndrome	0.0027	0.0341	CbGeAlD
Trisalicylate-choline—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.00261	0.033	CbGeAlD
Trisalicylate-choline—Sweating—Ritonavir—acquired immunodeficiency syndrome	0.0026	0.00284	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Didanosine—acquired immunodeficiency syndrome	0.00259	0.00283	CcSEcCtD
Trisalicylate-choline—PTGS2—digestive system—acquired immunodeficiency syndrome	0.00258	0.0326	CbGeAlD
Trisalicylate-choline—PTGS1—blood—acquired immunodeficiency syndrome	0.00257	0.0325	CbGeAlD
Trisalicylate-choline—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.00257	0.0028	CcSEcCtD
Trisalicylate-choline—Tinnitus—Efavirenz—acquired immunodeficiency syndrome	0.00256	0.0028	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Didanosine—acquired immunodeficiency syndrome	0.00256	0.0028	CcSEcCtD
Trisalicylate-choline—Epistaxis—Ritonavir—acquired immunodeficiency syndrome	0.00256	0.00279	CcSEcCtD
Trisalicylate-choline—Flushing—Efavirenz—acquired immunodeficiency syndrome	0.00255	0.00279	CcSEcCtD
Trisalicylate-choline—Anorexia—Nevirapine—acquired immunodeficiency syndrome	0.00253	0.00276	CcSEcCtD
Trisalicylate-choline—Oedema—Abacavir—acquired immunodeficiency syndrome	0.00252	0.00275	CcSEcCtD
Trisalicylate-choline—Pain—Didanosine—acquired immunodeficiency syndrome	0.00252	0.00275	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Delavirdine—acquired immunodeficiency syndrome	0.00249	0.00272	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Indinavir—acquired immunodeficiency syndrome	0.00248	0.00271	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.00248	0.00271	CcSEcCtD
Trisalicylate-choline—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.00248	0.0313	CbGeAlD
Trisalicylate-choline—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.00247	0.0027	CcSEcCtD
Trisalicylate-choline—Epistaxis—Saquinavir—acquired immunodeficiency syndrome	0.00246	0.00269	CcSEcCtD
Trisalicylate-choline—PTGS2—blood—acquired immunodeficiency syndrome	0.00246	0.0311	CbGeAlD
Trisalicylate-choline—Tinnitus—Delavirdine—acquired immunodeficiency syndrome	0.00245	0.00268	CcSEcCtD
Trisalicylate-choline—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.00245	0.00267	CcSEcCtD
Trisalicylate-choline—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.00244	0.00266	CcSEcCtD
Trisalicylate-choline—Hepatitis—Ritonavir—acquired immunodeficiency syndrome	0.00243	0.00266	CcSEcCtD
Trisalicylate-choline—Hallucination—Ritonavir—acquired immunodeficiency syndrome	0.00242	0.00264	CcSEcCtD
Trisalicylate-choline—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.0024	0.00262	CcSEcCtD
Trisalicylate-choline—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.00239	0.00261	CcSEcCtD
Trisalicylate-choline—Sweating—Lamivudine—acquired immunodeficiency syndrome	0.00239	0.00261	CcSEcCtD
Trisalicylate-choline—PTGS1—vagina—acquired immunodeficiency syndrome	0.00238	0.0301	CbGeAlD
Trisalicylate-choline—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.00238	0.0301	CbGeAlD
Trisalicylate-choline—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.00237	0.0299	CbGeAlD
Trisalicylate-choline—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.00236	0.00257	CcSEcCtD
Trisalicylate-choline—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.00235	0.00257	CcSEcCtD
Trisalicylate-choline—Epistaxis—Lamivudine—acquired immunodeficiency syndrome	0.00235	0.00256	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Efavirenz—acquired immunodeficiency syndrome	0.00234	0.00256	CcSEcCtD
Trisalicylate-choline—Hepatitis—Saquinavir—acquired immunodeficiency syndrome	0.00234	0.00256	CcSEcCtD
Trisalicylate-choline—Hallucination—Saquinavir—acquired immunodeficiency syndrome	0.00233	0.00255	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.0023	0.00252	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.0023	0.00251	CcSEcCtD
Trisalicylate-choline—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.00229	0.0025	CcSEcCtD
Trisalicylate-choline—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00229	0.0025	CcSEcCtD
Trisalicylate-choline—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.00228	0.00249	CcSEcCtD
Trisalicylate-choline—PTGS2—vagina—acquired immunodeficiency syndrome	0.00228	0.0288	CbGeAlD
Trisalicylate-choline—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.00227	0.00248	CcSEcCtD
Trisalicylate-choline—Tinnitus—Ritonavir—acquired immunodeficiency syndrome	0.00227	0.00248	CcSEcCtD
Trisalicylate-choline—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00227	0.00247	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.00226	0.00247	CcSEcCtD
Trisalicylate-choline—Flushing—Ritonavir—acquired immunodeficiency syndrome	0.00226	0.00247	CcSEcCtD
Trisalicylate-choline—PTGS1—lung—acquired immunodeficiency syndrome	0.00225	0.0285	CbGeAlD
Trisalicylate-choline—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.00225	0.00246	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.00224	0.00245	CcSEcCtD
Trisalicylate-choline—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.00224	0.00245	CcSEcCtD
Trisalicylate-choline—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.00223	0.00244	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.00223	0.00244	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.00222	0.00243	CcSEcCtD
Trisalicylate-choline—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.00222	0.00243	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.00221	0.00242	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00221	0.00242	CcSEcCtD
Trisalicylate-choline—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00219	0.0024	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.00219	0.00239	CcSEcCtD
Trisalicylate-choline—Pain—Stavudine—acquired immunodeficiency syndrome	0.00219	0.00239	CcSEcCtD
Trisalicylate-choline—Constipation—Stavudine—acquired immunodeficiency syndrome	0.00219	0.00239	CcSEcCtD
Trisalicylate-choline—Shock—Zidovudine—acquired immunodeficiency syndrome	0.00219	0.00239	CcSEcCtD
Trisalicylate-choline—Tinnitus—Saquinavir—acquired immunodeficiency syndrome	0.00218	0.00238	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00218	0.00238	CcSEcCtD
Trisalicylate-choline—Pain—Abacavir—acquired immunodeficiency syndrome	0.00215	0.00235	CcSEcCtD
Trisalicylate-choline—PTGS2—lung—acquired immunodeficiency syndrome	0.00215	0.0272	CbGeAlD
Trisalicylate-choline—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.00215	0.00235	CcSEcCtD
Trisalicylate-choline—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.00212	0.00231	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.00211	0.00231	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.00211	0.00231	CcSEcCtD
Trisalicylate-choline—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.0021	0.0023	CcSEcCtD
Trisalicylate-choline—PTGS1—nervous system—acquired immunodeficiency syndrome	0.00209	0.0264	CbGeAlD
Trisalicylate-choline—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00208	0.00228	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.00208	0.00227	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.00207	0.00227	CcSEcCtD
Trisalicylate-choline—Oedema—Indinavir—acquired immunodeficiency syndrome	0.00207	0.00226	CcSEcCtD
Trisalicylate-choline—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00205	0.00224	CcSEcCtD
Trisalicylate-choline—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.00204	0.00223	CcSEcCtD
Trisalicylate-choline—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00204	0.00223	CcSEcCtD
Trisalicylate-choline—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00204	0.00223	CcSEcCtD
Trisalicylate-choline—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00204	0.00222	CcSEcCtD
Trisalicylate-choline—Shock—Indinavir—acquired immunodeficiency syndrome	0.00203	0.00222	CcSEcCtD
Trisalicylate-choline—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00203	0.00222	CcSEcCtD
Trisalicylate-choline—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00202	0.00221	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00202	0.0022	CcSEcCtD
Trisalicylate-choline—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.00201	0.0254	CbGeAlD
Trisalicylate-choline—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.002	0.00219	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.002	0.00218	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.002	0.00218	CcSEcCtD
Trisalicylate-choline—PTGS2—nervous system—acquired immunodeficiency syndrome	0.00199	0.0252	CbGeAlD
Trisalicylate-choline—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00198	0.00216	CcSEcCtD
Trisalicylate-choline—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.00197	0.00215	CcSEcCtD
Trisalicylate-choline—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.00197	0.00215	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00196	0.00214	CcSEcCtD
Trisalicylate-choline—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00194	0.00212	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.00193	0.00211	CcSEcCtD
Trisalicylate-choline—Shock—Efavirenz—acquired immunodeficiency syndrome	0.00192	0.0021	CcSEcCtD
Trisalicylate-choline—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.00192	0.0243	CbGeAlD
Trisalicylate-choline—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00192	0.0021	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.0019	0.00208	CcSEcCtD
Trisalicylate-choline—Pain—Zidovudine—acquired immunodeficiency syndrome	0.0019	0.00208	CcSEcCtD
Trisalicylate-choline—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.0019	0.00208	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00189	0.00206	CcSEcCtD
Trisalicylate-choline—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.00188	0.00206	CcSEcCtD
Trisalicylate-choline—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00187	0.00205	CcSEcCtD
Trisalicylate-choline—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00187	0.00205	CcSEcCtD
Trisalicylate-choline—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00187	0.00204	CcSEcCtD
Trisalicylate-choline—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.00186	0.00203	CcSEcCtD
Trisalicylate-choline—Rash—Didanosine—acquired immunodeficiency syndrome	0.00186	0.00203	CcSEcCtD
Trisalicylate-choline—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00186	0.00203	CcSEcCtD
Trisalicylate-choline—Headache—Didanosine—acquired immunodeficiency syndrome	0.00185	0.00202	CcSEcCtD
Trisalicylate-choline—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00184	0.00201	CcSEcCtD
Trisalicylate-choline—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00184	0.00201	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00183	0.002	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00182	0.00199	CcSEcCtD
Trisalicylate-choline—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00182	0.00198	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00181	0.00198	CcSEcCtD
Trisalicylate-choline—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00181	0.00198	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00181	0.00197	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.0018	0.00196	CcSEcCtD
Trisalicylate-choline—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00178	0.00195	CcSEcCtD
Trisalicylate-choline—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00178	0.00195	CcSEcCtD
Trisalicylate-choline—Pain—Indinavir—acquired immunodeficiency syndrome	0.00177	0.00193	CcSEcCtD
Trisalicylate-choline—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00177	0.00193	CcSEcCtD
Trisalicylate-choline—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00177	0.00193	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00176	0.00192	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00175	0.00191	CcSEcCtD
Trisalicylate-choline—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00175	0.00191	CcSEcCtD
Trisalicylate-choline—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00175	0.00191	CcSEcCtD
Trisalicylate-choline—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00174	0.0019	CcSEcCtD
Trisalicylate-choline—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00174	0.0019	CcSEcCtD
Trisalicylate-choline—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00173	0.00189	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00172	0.00188	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00172	0.00188	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.0017	0.00186	CcSEcCtD
Trisalicylate-choline—Shock—Ritonavir—acquired immunodeficiency syndrome	0.0017	0.00186	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.0017	0.00186	CcSEcCtD
Trisalicylate-choline—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.0017	0.00185	CcSEcCtD
Trisalicylate-choline—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00169	0.00185	CcSEcCtD
Trisalicylate-choline—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00168	0.00184	CcSEcCtD
Trisalicylate-choline—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.00168	0.00183	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00167	0.00183	CcSEcCtD
Trisalicylate-choline—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00167	0.00182	CcSEcCtD
Trisalicylate-choline—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00167	0.00182	CcSEcCtD
Trisalicylate-choline—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00167	0.00182	CcSEcCtD
Trisalicylate-choline—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00167	0.00182	CcSEcCtD
Trisalicylate-choline—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00167	0.00182	CcSEcCtD
Trisalicylate-choline—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00166	0.00182	CcSEcCtD
Trisalicylate-choline—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00166	0.00182	CcSEcCtD
Trisalicylate-choline—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00166	0.00181	CcSEcCtD
Trisalicylate-choline—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.00165	0.0018	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00165	0.0018	CcSEcCtD
Trisalicylate-choline—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00164	0.00179	CcSEcCtD
Trisalicylate-choline—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00164	0.00179	CcSEcCtD
Trisalicylate-choline—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00163	0.00178	CcSEcCtD
Trisalicylate-choline—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00163	0.00178	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.00162	0.00177	CcSEcCtD
Trisalicylate-choline—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00162	0.00177	CcSEcCtD
Trisalicylate-choline—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00162	0.00177	CcSEcCtD
Trisalicylate-choline—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00162	0.00176	CcSEcCtD
Trisalicylate-choline—Rash—Stavudine—acquired immunodeficiency syndrome	0.00161	0.00176	CcSEcCtD
Trisalicylate-choline—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00161	0.00176	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00161	0.00176	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00161	0.00176	CcSEcCtD
Trisalicylate-choline—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00161	0.00176	CcSEcCtD
Trisalicylate-choline—Headache—Stavudine—acquired immunodeficiency syndrome	0.0016	0.00175	CcSEcCtD
Trisalicylate-choline—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.0016	0.00175	CcSEcCtD
Trisalicylate-choline—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.0016	0.00175	CcSEcCtD
Trisalicylate-choline—Pain—Delavirdine—acquired immunodeficiency syndrome	0.0016	0.00175	CcSEcCtD
Trisalicylate-choline—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.0016	0.00175	CcSEcCtD
Trisalicylate-choline—PTGS1—brain—acquired immunodeficiency syndrome	0.0016	0.0202	CbGeAlD
Trisalicylate-choline—Rash—Abacavir—acquired immunodeficiency syndrome	0.00159	0.00174	CcSEcCtD
Trisalicylate-choline—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00159	0.00173	CcSEcCtD
Trisalicylate-choline—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00159	0.00173	CcSEcCtD
Trisalicylate-choline—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.00159	0.00173	CcSEcCtD
Trisalicylate-choline—Headache—Abacavir—acquired immunodeficiency syndrome	0.00158	0.00172	CcSEcCtD
Trisalicylate-choline—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00157	0.00172	CcSEcCtD
Trisalicylate-choline—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00157	0.00172	CcSEcCtD
Trisalicylate-choline—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00156	0.00171	CcSEcCtD
Trisalicylate-choline—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00155	0.0017	CcSEcCtD
Trisalicylate-choline—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00155	0.0017	CcSEcCtD
Trisalicylate-choline—PTGS1—lymph node—acquired immunodeficiency syndrome	0.00154	0.0195	CbGeAlD
Trisalicylate-choline—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00154	0.00168	CcSEcCtD
Trisalicylate-choline—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00154	0.00168	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00153	0.00168	CcSEcCtD
Trisalicylate-choline—PTGS2—brain—acquired immunodeficiency syndrome	0.00152	0.0193	CbGeAlD
Trisalicylate-choline—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00152	0.00166	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00152	0.00166	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00152	0.00166	CcSEcCtD
Trisalicylate-choline—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00152	0.00166	CcSEcCtD
Trisalicylate-choline—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.00151	0.00165	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.0015	0.00164	CcSEcCtD
Trisalicylate-choline—Nausea—Abacavir—acquired immunodeficiency syndrome	0.0015	0.00163	CcSEcCtD
Trisalicylate-choline—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00148	0.00162	CcSEcCtD
Trisalicylate-choline—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00148	0.00162	CcSEcCtD
Trisalicylate-choline—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00148	0.00162	CcSEcCtD
Trisalicylate-choline—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00148	0.00161	CcSEcCtD
Trisalicylate-choline—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00148	0.00161	CcSEcCtD
Trisalicylate-choline—PTGS2—lymph node—acquired immunodeficiency syndrome	0.00147	0.0186	CbGeAlD
Trisalicylate-choline—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00147	0.00161	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00146	0.0016	CcSEcCtD
Trisalicylate-choline—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00146	0.0016	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00145	0.00158	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00142	0.00156	CcSEcCtD
Trisalicylate-choline—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00142	0.00155	CcSEcCtD
Trisalicylate-choline—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00142	0.00155	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00141	0.00155	CcSEcCtD
Trisalicylate-choline—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00141	0.00154	CcSEcCtD
Trisalicylate-choline—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00141	0.00154	CcSEcCtD
Trisalicylate-choline—Rash—Zidovudine—acquired immunodeficiency syndrome	0.0014	0.00153	CcSEcCtD
Trisalicylate-choline—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.0014	0.00153	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.0014	0.00153	CcSEcCtD
Trisalicylate-choline—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00139	0.00152	CcSEcCtD
Trisalicylate-choline—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00138	0.00151	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.00138	0.00151	CcSEcCtD
Trisalicylate-choline—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00137	0.0015	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00137	0.0015	CcSEcCtD
Trisalicylate-choline—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00137	0.00149	CcSEcCtD
Trisalicylate-choline—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00136	0.00148	CcSEcCtD
Trisalicylate-choline—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00136	0.00148	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00134	0.00146	CcSEcCtD
Trisalicylate-choline—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00132	0.00144	CcSEcCtD
Trisalicylate-choline—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00132	0.00144	CcSEcCtD
Trisalicylate-choline—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00132	0.00144	CcSEcCtD
Trisalicylate-choline—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00131	0.00144	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00131	0.00143	CcSEcCtD
Trisalicylate-choline—Rash—Indinavir—acquired immunodeficiency syndrome	0.0013	0.00142	CcSEcCtD
Trisalicylate-choline—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.0013	0.00142	CcSEcCtD
Trisalicylate-choline—Headache—Indinavir—acquired immunodeficiency syndrome	0.0013	0.00141	CcSEcCtD
Trisalicylate-choline—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00129	0.00141	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00128	0.0014	CcSEcCtD
Trisalicylate-choline—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00126	0.00138	CcSEcCtD
Trisalicylate-choline—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00124	0.00136	CcSEcCtD
Trisalicylate-choline—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00124	0.00135	CcSEcCtD
Trisalicylate-choline—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00123	0.00135	CcSEcCtD
Trisalicylate-choline—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00123	0.00134	CcSEcCtD
Trisalicylate-choline—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00123	0.00134	CcSEcCtD
Trisalicylate-choline—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00122	0.00134	CcSEcCtD
Trisalicylate-choline—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00122	0.00134	CcSEcCtD
Trisalicylate-choline—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00119	0.0013	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00118	0.00129	CcSEcCtD
Trisalicylate-choline—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00118	0.00129	CcSEcCtD
Trisalicylate-choline—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00118	0.00129	CcSEcCtD
Trisalicylate-choline—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00118	0.00129	CcSEcCtD
Trisalicylate-choline—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00117	0.00128	CcSEcCtD
Trisalicylate-choline—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00116	0.00127	CcSEcCtD
Trisalicylate-choline—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00114	0.00125	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00114	0.00124	CcSEcCtD
Trisalicylate-choline—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00112	0.00123	CcSEcCtD
Trisalicylate-choline—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00111	0.00121	CcSEcCtD
Trisalicylate-choline—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.0011	0.0012	CcSEcCtD
Trisalicylate-choline—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.0011	0.0012	CcSEcCtD
Trisalicylate-choline—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00109	0.00119	CcSEcCtD
Trisalicylate-choline—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00109	0.00119	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00109	0.00119	CcSEcCtD
Trisalicylate-choline—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00108	0.00118	CcSEcCtD
Trisalicylate-choline—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00106	0.00116	CcSEcCtD
Trisalicylate-choline—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00105	0.00115	CcSEcCtD
Trisalicylate-choline—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00105	0.00115	CcSEcCtD
Trisalicylate-choline—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00105	0.00114	CcSEcCtD
Trisalicylate-choline—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00104	0.00114	CcSEcCtD
Trisalicylate-choline—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00103	0.00112	CcSEcCtD
Trisalicylate-choline—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00101	0.0011	CcSEcCtD
Trisalicylate-choline—Rash—Lamivudine—acquired immunodeficiency syndrome	0.001	0.00109	CcSEcCtD
Trisalicylate-choline—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.001	0.00109	CcSEcCtD
Trisalicylate-choline—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000994	0.00109	CcSEcCtD
Trisalicylate-choline—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000988	0.00108	CcSEcCtD
Trisalicylate-choline—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000943	0.00103	CcSEcCtD
